NYSE: AMRZAmrize Ltd Stock
$52.04-0.85 (-1.61%)
Updated May 11, 2026
AMRZ Price
$52.04
Fair Value Price
N/A
Market Cap
$28.81B
52 Week Low
$44.12
52 Week High
$65.94
P/E
24.78x
P/B
2.2x
P/S
2.6x
PEG
1.14x
Dividend Yield
1.27%
Revenue
$11.91B
Earnings
$1.16B
Gross Margin
25.4%
Operating Margin
15.66%
Profit Margin
9.7%
Debt to Equity
0.85
Operating Cash Flow
$2B
Beta
1.33
Next Earnings
May 14, 2026
Ex-Dividend
May 12, 2026
Next Dividend
May 20, 2026
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AMRZ's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Building Material
Industry Rating
D
AMRZ
Ranked#8 of 15
Ranked#8 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.75 | B | |
| $31.60 | C | |
| $13.29 | C |
Be the first to know about important AMRZ news, forecast changes, insider trades & much more!
AMRZ News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AMRZ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AMRZ ($52.04) is trading above its intrinsic value of $27.23, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AMRZ is poor value based on its earnings relative to its share price (24.78x), compared to the US market average (22.24x)
P/E vs Market Valuation
AMRZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more AMRZ due diligence checks available for Premium users.
Valuation
AMRZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
24.78x
Industry
27.63x
Market
22.24x
AMRZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AMRZ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
AMRZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.2x
Industry
2.75x
AMRZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
AMRZ price to earnings growth (PEG)
For valuing profitable companies with growth potential
AMRZ is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
AMRZ's financial health
Profit margin
Revenue
$2.2B
Net Income
-$116.0M
Profit Margin
-5.3%
AMRZ's Earnings (EBIT) of $1.87B... subscribe to Premium to read more.
Interest Coverage Financials
AMRZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.3B
Liabilities
$11.2B
Debt to equity
0.85
AMRZ's short-term assets ($4.28B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMRZ's long-term liabilities ($8.13B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMRZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$896.0M
Investing
-$659.0M
Financing
$743.0M
AMRZ's operating cash flow ($2.17B)... subscribe to Premium to read more.
Debt Coverage Financials
AMRZ vs Building Material Stocks
Amrize Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.